V Steen

Summary

Affiliation: Georgetown University
Country: USA

Publications

  1. ncbi request reprint Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody
    Virginia D Steen
    Department of Medicine, Division of Rheumatology, Allergy and Immunology, Georgetown University, 3800 Reservoir Road, Washington, DC 20007, USA
    J Rheumatol 34:2230-5. 2007
  2. pmc A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis
    Virginia Steen
    Georgetown University School of Medicine, Washington, DC 20007, USA
    Arthritis Rheum 64:2986-94. 2012
  3. doi request reprint Digital ulcers: overt vascular disease in systemic sclerosis
    V Steen
    Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA
    Rheumatology (Oxford) 48:iii19-24. 2009
  4. doi request reprint Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis
    Virginia Steen
    Georgetown University School of Medicine, Georgetown University, Department of Medicine, LL Gorman, Washington, DC 20007, USA
    Chest 134:146-51. 2008
  5. doi request reprint The many faces of scleroderma
    Virginia D Steen
    Department of Medicine, Georgetown University, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA
    Rheum Dis Clin North Am 34:1-15; v. 2008
  6. ncbi request reprint Pregnancy in scleroderma
    Virginia D Steen
    Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA
    Rheum Dis Clin North Am 33:345-58, vii. 2007
  7. pmc Changes in causes of death in systemic sclerosis, 1972-2002
    Virginia D Steen
    Georgetown University, Washington, DC 20007, USA
    Ann Rheum Dis 66:940-4. 2007
  8. ncbi request reprint Treatment of systemic sclerosis
    V D Steen
    Department of Medicine, Georgetown University, Washington, DC, USA
    Am J Clin Dermatol 2:315-25. 2001
  9. ncbi request reprint Targeted therapy for systemic sclerosis
    Virginia Steen
    Medstar Georgetown University, Division of Rheumatology, Immunology, and Allergy, 3800 Reservoir Road NW, LL Gorman, Washington, DC 20007, USA
    Autoimmun Rev 5:122-4. 2006
  10. ncbi request reprint The lung in systemic sclerosis
    Virginia D Steen
    Georgetown University Medical Center, 3800 Reservoir Road, LL Kober Cogan Building, Washington, DC 20007, USA
    J Clin Rheumatol 11:40-6. 2005

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody
    Virginia D Steen
    Department of Medicine, Division of Rheumatology, Allergy and Immunology, Georgetown University, 3800 Reservoir Road, Washington, DC 20007, USA
    J Rheumatol 34:2230-5. 2007
    ..Our study focuses on lung disease in patients with a nucleolar antibody in comparison to other scleroderma-specific autoantibodies...
  2. pmc A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis
    Virginia Steen
    Georgetown University School of Medicine, Washington, DC 20007, USA
    Arthritis Rheum 64:2986-94. 2012
    ....
  3. doi request reprint Digital ulcers: overt vascular disease in systemic sclerosis
    V Steen
    Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA
    Rheumatology (Oxford) 48:iii19-24. 2009
    ....
  4. doi request reprint Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis
    Virginia Steen
    Georgetown University School of Medicine, Georgetown University, Department of Medicine, LL Gorman, Washington, DC 20007, USA
    Chest 134:146-51. 2008
    ..This study looks at the use of an exercise echocardiogram in identifying patients who may have PAH and may be candidates for early therapeutic intervention...
  5. doi request reprint The many faces of scleroderma
    Virginia D Steen
    Department of Medicine, Georgetown University, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA
    Rheum Dis Clin North Am 34:1-15; v. 2008
    ..These antibodies should be used in performing clinical trials and in doing genetic and basic research. Hopefully, these scleroderma antibodies will lead to a better understanding of the pathogenesis of scleroderma...
  6. ncbi request reprint Pregnancy in scleroderma
    Virginia D Steen
    Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA
    Rheum Dis Clin North Am 33:345-58, vii. 2007
    ..All patients who become pregnant during this high-risk time should be monitored extremely carefully, particularly for renal crisis...
  7. pmc Changes in causes of death in systemic sclerosis, 1972-2002
    Virginia D Steen
    Georgetown University, Washington, DC 20007, USA
    Ann Rheum Dis 66:940-4. 2007
    ..Survival of scleroderma has changed since the renal crisis treatment has become possible...
  8. ncbi request reprint Treatment of systemic sclerosis
    V D Steen
    Department of Medicine, Georgetown University, Washington, DC, USA
    Am J Clin Dermatol 2:315-25. 2001
    ..Although an overall remittive therapy has not yet been determined, new, potentially useful agents are being investigated...
  9. ncbi request reprint Targeted therapy for systemic sclerosis
    Virginia Steen
    Medstar Georgetown University, Division of Rheumatology, Immunology, and Allergy, 3800 Reservoir Road NW, LL Gorman, Washington, DC 20007, USA
    Autoimmun Rev 5:122-4. 2006
    ..All of these factors are influenced by unknown inciting agents and the permissive genetic background...
  10. ncbi request reprint The lung in systemic sclerosis
    Virginia D Steen
    Georgetown University Medical Center, 3800 Reservoir Road, LL Kober Cogan Building, Washington, DC 20007, USA
    J Clin Rheumatol 11:40-6. 2005
  11. ncbi request reprint Autoantibodies in systemic sclerosis
    Virginia D Steen
    Department of Medicine, Georgetown University, Washington, DC 2007, USA
    Semin Arthritis Rheum 35:35-42. 2005
    ..To describe the clinical, laboratory, and prognostic features associated with the scleroderma-specific autoantibodies...
  12. pmc Predictors of end stage lung disease in systemic sclerosis
    V Steen
    Georgetown University, Washington DC, USA
    Ann Rheum Dis 62:97-9. 2003
  13. ncbi request reprint The heart in systemic sclerosis
    Virginia Steen
    Georgetown University, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA
    Curr Rheumatol Rep 6:137-40. 2004
    ..More extensive evaluation of the conduction and the arrhythmia ablative therapy has helped manage these life-threatening complications...
  14. ncbi request reprint Assessment of kidney involvement
    V D Steen
    Georgetown University School of Medicine, Division of Rheumatology, Allergy and Clinical Immunology, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA
    Clin Exp Rheumatol 21:S29-31. 2003
    ..In clinical investigations SSc patients developing arterial hypertension after the disease onset (new onset hypertension) without SRC should also be reported...
  15. ncbi request reprint Scleroderma renal crisis
    Virginia D Steen
    Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Georgetown University, 3800 Reservoir Road, NW LL Gorman, Washington, DC 20007, USA
    Rheum Dis Clin North Am 29:315-33. 2003
    ..Prompt diagnosis and early, aggressive initiation of therapy with ACE inhibitors will result in the most optimal outcome...
  16. ncbi request reprint Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease
    Kenneth Scalapino
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
    J Rheumatol 33:1004-13. 2006
    ..To describe the differences between patients with systemic sclerosis (SSc) having childhood versus adult onset evaluated at a single medical center...
  17. ncbi request reprint Kidney disease other than renal crisis in patients with diffuse scleroderma
    Virginia D Steen
    Georgetown University, Washington, DC 20007, USA
    J Rheumatol 32:649-55. 2005
    ..To determine the frequency and severity of kidney abnormalities in patients with diffuse scleroderma...
  18. doi request reprint Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors
    Kristin M Ingraham
    Division of Rheumatology, Georgetown University, Washington, DC, USA
    J Rheumatol 37:603-7. 2010
    ....
  19. ncbi request reprint Development of a provisional core set of response measures for clinical trials of systemic sclerosis
    D Khanna
    Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, California 90095, USA
    Ann Rheum Dis 67:703-9. 2008
    ..To develop a provisional core set of response measures for clinical trials of systemic sclerosis (SSc)...
  20. ncbi request reprint Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial
    Dinesh Khanna
    Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, Los Angeles, California, USA
    J Rheumatol 32:832-40. 2005
    ....
  21. ncbi request reprint Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody
    Achini Perera
    University of Pittsburgh School of Medicine, 3500 Terrace Street, Pittsburgh, PA 15261, USA
    Arthritis Rheum 56:2740-6. 2007
    ....
  22. ncbi request reprint A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement
    Ghaith M Mitri
    HealthStar Physicians, Jefferson City, Tennessee, USA
    Arthritis Rheum 48:203-9. 2003
    ..To compare anti-Th/To-positive and anticentromere antibody (ACA)-positive patients with limited cutaneous systemic sclerosis (lcSSc)...
  23. ncbi request reprint Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension
    Lionel Schachna
    Johns Hopkins University, Baltimore, Maryland 21224, USA
    Arthritis Rheum 54:3954-61. 2006
    ..This study was undertaken to evaluate whether patients with systemic sclerosis (scleroderma), a systemic autoimmune rheumatic disorder, would receive similar benefit from this intervention...
  24. ncbi request reprint Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study
    Dinesh Khanna
    David Geffen School of Medicine, University of California, Los Angeles, USA
    Arthritis Rheum 52:592-600. 2005
    ....
  25. pmc Clinical trials in systemic sclerosis: lessons learned and outcomes
    Marco Matucci-Cerinic
    Division of Medicine and Surgery, Division of Medicine I and Rheumatology, Villa Monna Tessa, Viale Pieraccini, I 50139 Florence, Italy
    Arthritis Res Ther 9:S7. 2007
    ....